España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Enovis
ENOV
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$47.99
1.36
2.92%
At close: -
$47.99
0.00
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Enovis (ENOV) Forecast
News
Earnings
Enovis (ENOV) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Enovis (NYSE:ENOV) Stock
Enovis Stock (NYSE: ENOV)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, January 08, 2025
Instacart Grows Stronger: S&P MidCap 400 Inclusion, Ulta Partnership Boosts Stock
Nabaparna Bhattacharya
Tuesday, January 07, 2025
Enovis To Replace Arch Resources In S&P Small...
Benzinga Newsdesk
Maplebear To Replace Enovis In S&P MidCap 400...
Benzinga Newsdesk
Thursday, November 07, 2024
Needham Reiterates Buy on Enovis, Maintains $...
Benzinga Newsdesk
Wednesday, November 06, 2024
Enovis Expects 2024 Adjusted EPS Of $2.75-$2....
Benzinga Newsdesk
Enovis Narrowed Its Revenue Range And Adjuste...
Benzinga Newsdesk
Enovis Q3 2024 Adj EPS $0.73 Beats $0.62 Esti...
Benzinga Newsdesk
Thursday, October 03, 2024
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says
Vandana Singh
The Latest Analyst Ratings For Enovis
Benzinga Insights
JMP Securities Initiates Coverage On Enovis w...
Benzinga Newsdesk
Tuesday, October 01, 2024
Evercore ISI Group Maintains Outperform on En...
Benzinga Newsdesk
Thursday, August 08, 2024
JP Morgan Maintains Neutral on Enovis, Lowers...
Benzinga Newsdesk
Needham Maintains Buy on Enovis, Lowers Price...
Benzinga Newsdesk
Wednesday, August 07, 2024
Enovis Expects 2024 Adjusted EPS Of $2.62-$2....
Benzinga Newsdesk
Enovis Expects 2024 Revenue Of $2.08B-$2.13B ...
Benzinga Newsdesk
Enovis Q2 2024 Adj. EPS $0.62 Beats $0.59 Est...
Benzinga Newsdesk
Friday, July 12, 2024
Enovis Releases AltiVate Reverse Glenoid Syst...
Benzinga Newsdesk
Tuesday, July 02, 2024
Critical Insights From Enovis Analyst Ratings: What You Need To Know
Benzinga Insights
Evercore ISI Group Maintains Outperform on En...
Benzinga Newsdesk
Monday, June 24, 2024
5 Medical Info Systems Stock to Buy for a Stable Portfolio
Zacks
Friday, June 21, 2024
Top 3 Health Care Stocks That Could Blast Off In June
Avi Kapoor
Thursday, June 13, 2024
JP Morgan Initiates Coverage On Enovis with N...
Benzinga Newsdesk
Tuesday, May 07, 2024
Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month
Avi Kapoor
Friday, May 03, 2024
A Closer Look at 6 Analyst Recommendations For Enovis
Benzinga Insights
Needham Reiterates Buy on Enovis, Maintains $...
Benzinga Newsdesk
Thursday, May 02, 2024
Enovis shares are trading lower. The company ...
Benzinga Newsdesk
Enovis Expects 2024 Adjusted EBITDA Of $368M-...
Benzinga Newsdesk
Enovis Expects 2024 Adjusted EPS Of $2.52-$2....
Benzinga Newsdesk
Enovis Expects 2024 Revenue Of Approximate $2...
Benzinga Newsdesk
Enovis Q1 2024 Adj EPS $0.50 Beats $0.48 Esti...
Benzinga Newsdesk
Tuesday, April 16, 2024
Banzai Welcomes Over 580 New Customers In Q1,...
Benzinga Newsdesk
Wednesday, April 10, 2024
Needham Reiterates Buy on Enovis, Maintains $...
Benzinga Newsdesk
Friday, February 23, 2024
Canaccord Genuity Maintains Buy on Enovis, Ra...
Benzinga Newsdesk
Needham Maintains Buy on Enovis, Raises Price...
Benzinga Newsdesk
Thursday, February 22, 2024
Medtech Firm Enovis Sets Strong 2024 Targets As Q4 Earnings Beat Expectations, Analyst Says Growth Intact
Vandana Singh
Enovis Forecasts Fiscal Year 2024 Adjusted EP...
Benzinga Newsdesk
Enovis Forecasts Fiscal Year 2024 Revenues Of...
Benzinga Newsdesk
Enovis Q4 Adjusted EPS $0.79 Beats $0.74 Esti...
Benzinga Newsdesk
Earnings Scheduled For February 22, 2024
Benzinga Insights
Wednesday, February 21, 2024
Earnings Outlook For Enovis
Benzinga Insights
Tuesday, February 13, 2024
5 Analysts Have This To Say About Enovis
Benzinga Insights
Stephens & Co. Initiates Coverage On Enovis w...
Benzinga Newsdesk
Monday, January 22, 2024
UBS Initiates Coverage On Enovis with Buy Rat...
Benzinga Newsdesk
Monday, January 08, 2024
The Analyst Landscape: 6 Takes On Enovis
Benzinga Insights
Needham Maintains Buy on Enovis, Raises Price...
Benzinga Newsdesk
Wednesday, January 03, 2024
This Analyst Sees Durable Share Gains, Margin Expansion For Orthopedics-Focused Enovis
Vandana Singh
William Blair Initiates Coverage On Enovis wi...
Benzinga Newsdesk
Enovis Completes Acquisition Of LimaCorporate...
Benzinga Newsdesk
Wednesday, December 20, 2023
Canaccord Genuity Maintains Buy on Enovis, Ra...
Benzinga Newsdesk
Friday, December 15, 2023
This Analyst Selects Enovis As Top Pick For 2024: Spotlight On EMPOWR Revision Launch
Nabaparna Bhattacharya
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
